SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Jun-23 9:01 PM View: | Replimune Group, Inc. (REPL) | 13-Jun-23 | Market Sale (Planned) | 12,860 | $24.06 | $309,395.00 | (9%) 148.15K to 135.29K | (8%) |
18-May-23 8:34 PM View: | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 12,207 | $18.05 | $220,336.00 | (8%) 160.36K to 148.15K | |
04-Apr-23 8:01 PM View: | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 40,000 | -- | -- | 33% 120.36K to 160.36K | |
18-May-22 7:02 PM View: | Replimune Group, Inc. (REPL) | 16-May-22 | Sale | 5,473 | $14.59 | $79,851.10 | (4%) 125.83K to 120.36K | |
05-Apr-22 4:15 PM View: | Replimune Group, Inc. (REPL) | 01-Apr-22 | Grant | 52,500 | -- | -- | 72% 73.33K to 125.83K | |
11-May-21 9:01 PM View: | Replimune Group, Inc. (REPL) | 10-May-21 | Grant | 73,333 | -- | -- | 100% 0 to 73.33K | |
01-Mar-21 8:13 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 25-Feb-21 | Grant | 22,013 | -- | -- | 94% 23.39K to 45.4K | |
17-Feb-21 6:49 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 11-Feb-21 | Market Sale | 2,046 | $15.52 | $31,752.10 | (33%) 6.19K to 4.14K | 3% |
09-Feb-21 8:34 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 05-Feb-21 | Option Exercise | 5,650 | -- | -- | 1048% 0.54K to 6.19K | |
04-Nov-20 8:18 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 30-Oct-20 | Market Option Sale | 226 | $15.58 | $3,521.08 | (30%) 0.77K to 0.54K | (2%) |
04-Nov-20 8:18 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 28-Oct-20 | Option Exercise | 765 | -- | -- | 100% 0 to 0.77K | |
12-Dec-08 1:49 PM View: | Vion Pharmaceuticals Inc. (VION.OB) | 10-Dec-08 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |